Bookmark

Add to MyYahoo RSS

Questcor Pharmaceuticals News

News on Questcor Pharmaceuticals (Ticker: QCOR) continually updated from thousands of sources around the net.

Wednesday | Hispanic Business

Questcor Pharmaceuticals Inc Files (8-K) Disclosing Other Events

ITEM 8.01 OTHER EVENTS Settlement of Certain Litigation As previously disclosed at page 170 of the definitive joint proxy statement/prospectus dated under the heading "Litigation Relating to the Transaction," certain actions were filed by putative shareholders of shareholders because, among other things, the proposed merger in which Mallinckrodt ... (more)

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

Sat Jul 26, 2014

AmericanBankingNews.com

Questcor Pharmaceuticals Stock Rating Lowered by Oppenheimer

They currently have a $86.00 target price on the stock. Oppenheimer's target price would suggest a potential downside of 9.38% from the stock's previous close.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

Fri Jul 25, 2014

Reuters

Hedge fund Greenlight details short bets, still likes Apple

Hedge fund manager David Einhorn's Greenlight Capital told investors on Friday that it has short bets against supermarket chain Safeway Inc. and Questcor Pharmaceuticals which was is being taken over by Mallinckrodt Pharmaceuticals.

Comment?

Related Topix: Retail, Safeway, Grocery, Biotech, Startups, Questcor Pharmaceuticals

Thu Jul 24, 2014

AmericanBankingNews.com

Questcor Pharmaceuticals (QCOR) Posts Quarterly Earnings, Beats Expectations By $0.11 EPS

Questcor Pharmaceuticals announced its earnings results on Thursday. The company reported $1.85 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.74 by $0.11, StockRatingsNetwork.com reports.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

BioSpace

Questcor Pharmaceuticals, Inc. (Headquarters) Reports Record Second Quarter Financial Results

Net sales for H.P. ActharA Gel for the second quarter ended in non-GAAP net sales in the second quarter of June 2013.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals, Medicine, Health, Medicaid, Rheumatology

Reuters

MS drug sales drive Questcor profit

Questcor Pharmaceuticals Inc posted a 39.5 percent rise in quarterly profit, helped by strong sales of multiple sclerosis drug Acthar.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals, Medicine, Multiple Sclerosis, Health

Wed Jul 16, 2014

AmericanBankingNews.com

Questcor Pharmaceuticals Insider Don M. Bailey Sells 40,000 Shares

Questcor Pharmaceuticals Insider Don M. Bailey unloaded 40,000 shares of Questcor Pharmaceuticals stock in a transaction dated Monday, July 14th.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

Tue Jul 15, 2014

Seeking Alpha

Dumb Investment Of The Week: Mallinckrodt Plc

On April 7, 2014, Mallinckrodt Plc , a specialty pharmaceutical company, announced it entered into an agreement to purchase Questcor Pharmaceuticals for approximately $5.6B .

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals, Sun Microsystems, Computers, Hewlett Packard, Health Insurance, Health

Mon Jul 14, 2014

BioSpace

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals, Inc....

The registration statement on Form S-4 is available on the SEC's EDGAR system, and may be accessed at: http://www.sec.gov .

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals, Securities and Exchange Commission, Corporate / Securities Law, Law, US Securities and Exchange Commission, Financial Services, Medicine, Rheumatology

Fri Jul 11, 2014

BioSpace

Questcor Pharmaceuticals, Inc. (Headquarters) Finally Fesses Up To Adverse Events Data For Acthar

But according to a regulatory filing made by Questcor early Thursday, the number of patients reporting a so-called adverse event while using the drug last year represented almost 5 percent of prescriptions dispensed.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

Thu Jul 10, 2014

Seeking Alpha

Questcor's Acthar Gel: Clinical Usage Suggests Efficacy

Questcor Pharmaceuticals has a medication known as Acthar Gel, which has been manufactured since the 1950s.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

Thu Jul 03, 2014

AmericanBankingNews.com

Questcor Pharmaceuticals Reaches New 1-Year High at $94.87

Shares of Questcor Pharmaceuticals hit a new 52-week high during mid-day trading on Thursday , StockRatingsNetwork reports.

Comment?

Related Topix: Biotech, Startups, Questcor Pharmaceuticals

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••